Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?
Saved in:
| Title: | Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope? |
|---|---|
| Authors: | Marini BL; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, University of Michigan College of Pharmacy, Ann Arbor, Michigan., Perissinotti AJ; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, University of Michigan College of Pharmacy, Ann Arbor, Michigan., Bixby DL; Division of Hematology and Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan., Burke PW; Division of Hematology and Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan., Pettit KM; Division of Hematology and Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan., Benitez LL; Department of Pharmacy Services and Clinical Sciences, Michigan Medicine, University of Michigan College of Pharmacy, Ann Arbor, Michigan. |
| Source: | Cancer [Cancer] 2019 Nov 01; Vol. 125 (21), pp. 3890-3891. Date of Electronic Publication: 2019 Jul 10. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.32381 |
